HRAS and thyroid gland carcinoma: HRAS, a distinct subtype within the Ras GTPase family implicated in thyroid cancer [38, 39], had demonstrated that its expression in subcutaneous fat diminishes when caloric intake is restricted, thereby mitigating cancer signaling pathways in murine models [40].